Brief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
31/08/2026 02:51
BRIEF-Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway Aug 31 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
PIVOTAL MARBURG DATA SECURED FOR GALIDESIVIR FDA PATHWAY
RECEIVES LOA TO CROSS-REFERENCE MARBURG-ANGOLA NHP DATA IN FDA SUBMISSIONS
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic